Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement and renal disease.

L A Trouw1, M A Seelen, M R Daha

  • 1Department of Nephrology, D3-P-39, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. latrouw@lumc.nl

Molecular Immunology
|August 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation.

Journal of autoimmunity·2025
Same author

Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Nature communications·2025
Same author

Type 17-specific immune pathways are active in early spondyloarthritis.

RMD open·2023
Same author

Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals.

RMD open·2022
Same author

Anti-C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single-centre, cross-sectional study.

The British journal of dermatology·2021
Same author

Auto-antibodies to post-translationally modified proteins in osteoarthritis.

Osteoarthritis and cartilage·2021
Same journal

m6A modification of LINC00458 enhances HMOX1 stability via ELAVL1 recruitment to promote ferroptosis and aggravate asthma.

Molecular immunology·2026
Same journal

Overexpression of Hes1 inhibits cigarette smoke-induced mitochondrial apoptosis in AT2 cells by activating the Pgc-1α/Tfam signaling pathway.

Molecular immunology·2026
Same journal

Progesterone promotes favorable pregnancy outcomes in recurrent spontaneous, abortion by attenuating NK Cell overactivation and upregulating the cAMP/PKA/CREB signaling axis.

Molecular immunology·2026
Same journal

Oleanolic acid alleviates hepatic fibrosis by inhibiting liver macrophage recruitment and polarization.

Molecular immunology·2026
Same journal

Cordycepin attenuates diabetic nephropathy by dual-pathway activation of TFEB to restore autophagy and ameliorate podocyte injury.

Molecular immunology·2026
Same journal

Endothelial-derived TWEAK drives granulosa cell apoptosis in PCOS via the Fn14-oxidative stress axis.

Molecular immunology·2026
See all related articles

The complement system significantly impacts kidney diseases, influencing their development and resolution. Understanding its components and pathways offers new avenues for managing renal conditions.

Area of Science:

  • Nephrology
  • Immunology

Background:

  • The complement system plays a known role in renal disease.
  • Its involvement was previously inferred from kidney deposition and circulating levels.

Purpose of the Study:

  • To elucidate the modulating role of complement in the onset, development, and resolution of renal disease.
  • To explore the function of individual complement components and activation pathways.

Main Methods:

  • Review of recent studies on complement's role in renal disease.
  • Analysis of complement component deposition in renal tissues.
  • Monitoring of circulating complement levels during disease states.

Main Results:

  • Complement system actively modulates renal disease progression and resolution.

Related Experiment Videos

  • Specific complement components and activation pathways are implicated.
  • Potential complement regulatory strategies are identified.

    • Conclusions:

    • Complement system is integral to renal disease pathogenesis.
    • Targeting complement pathways presents therapeutic opportunities for kidney diseases.
    • Further research into complement regulation is crucial for clinical management.